CENTOGENE will be out in force to support AD/PD 2024 – the International Conference on Alzheimer's, and Parkinson's Diseases and related neurological disorders.
Following our recent announcement of our partnership with the Michael J. Fox Foundation to accelerate diagnoses and potential treatment options for the over 10 million people worldwide affected by Parkinson’s Disease, CENTOGENE will be out in force to support AD/PD 2024 – the International Conference on Alzheimer's, and Parkinson's Diseases and related neurological disorders. Pierre Engel will present on the groundbreaking CENTOGENE ROPAD study! VP Business Development Ana de Lilo will also be on hand and eager to engage Join me as we delve into cutting-edge research in neurodegenerative diseases. Looking forward to insightful discussions and networking opportunities.